Výsledky vyhledávání - "Huy Tram N Nguyen"

Epidural Fibrin Sealant Injection for the Management of Cerebrospinal Fluid Leak Following Dural Puncture in Children

Autor: Huy Tram N Nguyen, Stephanie A Armstrong, Bermans J. Iskandar, Susan L Rebsamen, James A Stadler

Publikováno v: Cureus

Cerebrospinal fluid (CSF) leak, intracranial hypotension, and postdural puncture headaches are common following dural punctures. Management usually consists of conservative treatments with medications (e.g. caffeine, nonsteroidal anti-inflammatory dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4695c4ca6d253b44b65bc15d2dd17930
https://doi.org/10.7759/cureus.6940

Zobrazit plný text záznamu

Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden

Autor: Laura Dovek, Timothy F. Cloughesy, Myung-Shin Sim, Albert Lai, Arliene Ravelo, Huy Tram N. Nguyen, Liang Yen Liu, Robert Harris, Byram Ozer, Daniel Lenchner, Richard M. Green, Nhung T Nguyen, Robert Elashoff, Benjamin M. Ellingson, Nicolas Sommer, Phioanh L. Nghiemphu

Publikováno v: Neuro-oncology practice, vol 6, iss 2

Background Since its approval for use in recurrent glioblastoma (GBM), the survival benefit of bevacizumab (Bev) remains to be demonstrated. To address this issue, we retrospectively examined survival from first recurrence in patients treated with Be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5eb25c25c268ce6c066359814f88fcd
https://escholarship.org/uc/item/03j1n5pd

Zobrazit plný text záznamu

Assessment of therapeutic response in patients with metastatic bone disease

Autor: Mark Clemons, Huy Tram N Nguyen, Andrew R Clamp, Sarah Danson, David E.C. Cole

Publikováno v: The Lancet Oncology. 5:607-616

Metastatic bone disease is common in cancer patients and causes substantial disease-related morbidity and mortality. However, several effective treatments are available for the management of these patients. Bisphosphonates, which inhibit osteoclast-m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2557984b928b83efd2cd5a768af7e6a
https://doi.org/10.1016/s1470-2045(04)01596-7

Zobrazit plný text záznamu

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited

Autor: Patrick T. Grogan, Huy Tram N Nguyen, H. Ian Robins

Publikováno v: The Lancet Oncology. 18:e708

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::78034c49f9dc30dda7fd42f4baa70613
https://doi.org/10.1016/s1470-2045(17)30857-4

Zobrazit plný text záznamu

Bevacizumab (Bev) to reduce the negative impact of glioblastoma (GBM) tumor size on survival from first recurrence

Autor: Laura Dovek, Liang Yen Liu, Robert Elashoff, Benjamin M. Ellingson, Arliene Ravelo, Nhung T Nguyen, Nicolas Sommer, Daniel Lenchner, Richard M. Green, Huy Tram N. Nguyen, Albert Lai, Timothy F. Cloughesy, Phioanh L. Nghiemphu, Robert J. Harris, Byram Ozer, Myung-Shin Sim

Publikováno v: Journal of Clinical Oncology. 35:2052-2052

2052 Background: Bev was FDA approved for recurrent GBM in 2009. However, the survival benefit from Bev in GBM remains to be demonstrated. Methods: We retrospectively identified 168 primary GBM patients diagnosed between 2001-2015 at UCLA and Kaiser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e13257dd9773a2ec3a142bd42de60fe
https://doi.org/10.1200/jco.2017.35.15_suppl.2052

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání